Reference
Novartis. Aimovig (erenumab) NICE Final Appraisal Document (FAD) publication - Novartis UK media statement. Internet Document : 11 Dec 2020. Available from: URL: https://www.novartis.co.uk/news/media-releases/aimovig-erenumab-nice-final-appraisal-document-fad-publication-novartis-uk-media
Rights and permissions
About this article
Cite this article
NICE recommends erenumab for migraine prevention. PharmacoEcon Outcomes News 869, 35 (2021). https://doi.org/10.1007/s40274-021-7402-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7402-z